News

August 16, 2019

Protein Treatment, GRF6019, Seen to Help Maintain Cognition in Alzheimer’s Patients in Phase 2 Trial

News

Alkahest’s experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer’s disease patients, results of a six-month Phase 2 clinical trial show. “These top-line results indicate ... Read more

August 14, 2019August 14, 2019

Blood Markers May ID People Most Likely to Gain Cognitively with Aerobic Exercise, Study Reports

News

Blood levels of certain molecules— metabolites and amino acids — may help to identify people with Alzheimer’s disease who are more likely to improve their cognitive skills in response to aerobic ... Read more

August 12, 2019August 12, 2019

AC Immune’s Anti-Tau Vaccine ACI-35.030 to Be Tested in Phase 1b/2a Trial

News

AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau vaccine called ACI-35.030 as a potential disease-modifying treatment for Alzheimer’s disease and other disorders characterized by ... Read more

August 9, 2019August 9, 2019

UAFS, Arkansas Senior Residence Use 3D Technology to Aid Recreational Therapy

News

To foster the cognitive stimulation of its Alzheimer’s disease (AD) residents, an Arkansas senior living center collaborated with the University of Arkansas – Fort Smith (UAFS) to produce recreational 3D-printed ... Read more

August 7, 2019August 7, 2019

AZTherapies Completes Enrollment for ALZT-OP1 Trial for Early Alzheimer’s

News

AZTherapies has completed enrollment for its Phase 3 COGNITE trial, testing the safety and efficacy of its investigational ALZT-OP1 for the treatment of early Alzheimer’s disease (AD). A total ... Read more

August 5, 2019August 5, 2019

Chemical Compound Can Restore Neural Function in Familial Alzheimer’s, Study Finds

News

A mutation in a gene linked to familial Alzheimer’s disease promotes the disease by reducing the points of contact between nerve cells and impairing neuronal communication, a study ... Read more

August 2, 2019August 2, 2019

$47M Federal Grant Adds Brain Imaging to Pivotal Lifestyle Interventions Study

News

The University of California, Berkeley (UC Berkeley) will receive an expected $47 million in a federal grant that will add advanced brain imaging to a pivotal study to determine ... Read more

July 31, 2019July 31, 2019

Longeveron Gets $3M Alzheimer’s Association Grant to Continue Stem Cell Study

News

Biopharmaceutical company Longeveron will use a $3 million Alzheimer’s Association grant to advance innovative research that uses adult stem cells to target neuroinflammation in people with mild Alzheimer’s disease ... Read more

July 29, 2019July 29, 2019

Carriers of CHRFAM7A gene Less Responsive to Cholinesterase Inhibitors, Study Suggests

News

Alzheimer’s disease patients carrying a gene found only in humans, called CHRFAM7A, are less responsive to cholinesterase inhibitors, a new study reports. These findings may explain why some therapeutic ... Read more

July 26, 2019July 26, 2019

Samus Therapeutics Launches Phase 1 Trial of Tau-targeting Therapy

News

Following the approval of its investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA), Samus Therapeutics is launching a Phase 1 trial in the United ... Read more

Pin It on Pinterest